Browsing by Subject "neuroinflammation"
Now showing items 1-4 of 4
-
PAM-2 decreases neuropathic pain in mice and modulates chemokine/cytokine production in human microglial cells
(Oklahoma State University Center for Health Services, 2020-02-28)Background: People worldwide suffer from neuropathic pain, and indicated medications are often either not effective or induce tolerance and abuse. Therefore, there is an urgent need to identify additional therapeutic options ... -
Protective effects of β-Funaltrexamine against LPS-induced CCL2 expression and behavioral deficits
(Oklahoma State University Center for Health Sciences, 2023-02-17)Background: Inflammation is present in both neurological and peripheral disorders. Specifically, inflammation is one of the common factors in diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), mood disorders ... -
Signaling pathways involved in IL-1beta-induced regulation of MOR expression in human neurons
(2008-12)Scope and Method of Study: -
β-Funaltrexamine protects against lipopolysaccharide-induced neuroinflammation and behavioral impairment
(Oklahoma State University Center for Health Sciences, 2022-02-18)Background: One of the commonalities present in a multitude of neurological disorders is inflammation. For this reason, targeting inflammation has emerged as a viable option for the potential treatment of neurological ...